Last ned 3/2011 - Kirurgen.no
Last ned 3/2011 - Kirurgen.no
Last ned 3/2011 - Kirurgen.no
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Introducing the new<br />
<strong>no</strong>n-surgical option<br />
for fecal incontinence<br />
Supporting Data: 1) Treating faecal incontinence with bulking-agent injections; Christine Norton; The Lancet, Volume 377, Issue 9770, Pages 971 - 972, 19 March <strong>2011</strong>; 2) Efficacy of dextra<strong>no</strong>mer in stabilised hyaluronic acid for<br />
treatment of faecal incontinence: a randomised, sham-controlled trial; Dr Wilhelm Graf PhD, Anders Mellgren PhD, Klaus E Matzel PhD, Tracy Hull PhD, Claes Johansson PhD, Mitch Bernstein MD, on behalf of the NASHA Dx Study<br />
Group; The Lancet, Volume 377, Issue 9770, Pages 997 - 1003, 19 March <strong>2011</strong>; 3) An Open-Label, Noncomparative,Multicenter Study to Evaluate Efficacy and Safety of NASHA/Dx Gel as a Bulking Agent for the Treatment of Fecal<br />
Incontinence; Giuseppe Dodi, Johannes Jongen, Fernando de la Portilla, Ma<strong>no</strong>j Raval, Donato F. Altomare, and Paul-Antoine Lehur; Hindawi Publishing Corporation Gastroenterology Research and Practice Volume 2010, Article<br />
ID 467136, 10 pages; 4) Submucosal Injection of Stabilized Nonanimal Hyaluronic Acid with Dextra<strong>no</strong>mer: A New Treatment Option for Fecal Incontinence; Johan Danielson, M.D. & Urban Karlbom, M.D., Ph.D. Ann-Cathrine<br />
Sonesson, R.N. & Tomas Wester, M.D., Ph.D. Wilhelm Graf, M.D., Ph.D.; Dis Colon Rectum 2009; 52: 1101-1106; 5) Anal inkontinens – utprøvning av en ny behandlingsmetode; T Dehli, R Lindsetmo, K Mevik, B Vonen; Tidsskr Nor<br />
Lægeforen Nr. 22 – 15. <strong>no</strong>vember 2007; 127:2934-6; 6) A randomized, controlled study of biofeedback and dextra<strong>no</strong>mer (Solesta) injection for treatment of anal incontinence; Trond Dehli; ESCP in Sorrento, Thursday 30 September<br />
2010, awarded ”Best Paper and Key<strong>no</strong>te Lecture”; 7) Quality of Life and Functional Results of Submucosal Injection Therapy Using Dextra<strong>no</strong>mer Hyaluronic Acid for Fecal Incontinence; Oliver Schwandner, MD, Marion Brunner, MD,<br />
and Otto Dietl, MD; Surgical In<strong>no</strong>vation XX(X) 1–6; 8) Positiver Effekt durch Polsterwirkung - Lokale Injektionstherapie bei Stuhlinkontinenz; Dr. Ingrid Hau<strong>no</strong>ld; Ärzte Woche 4 /2010; Springer-Verlag GmbH<br />
Oceana Therapeutics Ltd. Suite 602, Q House, 76 Furze Road, Sandyford Industrial Estate, Dublin 18, Ireland<br />
Tel: +353 (0)1 293 0153 Fax: +353 (0)1 293 0166 E-mail: International@oceanathera.com
Change language